Related Experiment Video
Updated: Jul 10, 2026
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
Nonpharmacological cognitive interventions in aging and dementia
Amarilis Acevedo1, David A Loewenstein
1Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, and Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, Florida 33140, USA. aacevedo3@med.miami.edu
Journal of Geriatric Psychiatry and Neurology
|November 16, 2007
Summary
Cognitive interventions show promise for older adults, aiding healthy individuals and those with neurodegenerative diseases like Alzheimer's. Further research is recommended to optimize these promising cognitive strategies.
Area of Science:
- Gerontology
- Neuroscience
- Cognitive Psychology
Background:
- Cognitive decline is a significant concern for aging populations.
- Cognitive interventions aim to improve memory, processing speed, and overall cognitive function in the elderly.
- Interventions are being developed for healthy aging, post-stroke/TBI rehabilitation, and neurodegenerative diseases like Alzheimer's.
Purpose of the Study:
- To review current cognitive intervention approaches for older adults.
- To highlight recent advancements in treating progressive neurocognitive conditions, especially Alzheimer's disease.
- To examine critical factors influencing intervention effectiveness.
Main Methods:
- Literature review of cognitive interventions in elderly populations.
- Focus on studies addressing healthy aging, traumatic brain injury (TBI), stroke, and Alzheimer's disease.
- Analysis of study design, outcome measures, population heterogeneity, and technological integration.
Main Results:
- Cognitive training enhances memory and processing speed in healthy older adults.
- Rehabilitation focuses on functional restoration for individuals with TBI and stroke.
- Emerging techniques target progressive neurocognitive disorders, including Alzheimer's disease.
- Consideration of ecological validity, functional outcomes, diverse populations, and technology is crucial.
Conclusions:
- Cognitive interventions offer significant potential for improving cognitive health in the elderly.
- Continued research is essential to refine and validate these interventions.
- Addressing methodological and population-specific factors will enhance intervention efficacy.
Related Concept Videos
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...